A Study of LY3405105 in Participants With Advanced Cancer



Status:Recruiting
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/5/2019
Start Date:January 25, 2019
End Date:May 5, 2022
Contact:There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Email:clinicaltrials.gov@lilly.com
Phone:1-317-615-4559

Use our guide to learn which trials are right for you!

A Phase 1a/1b Study of LY3405105 Administered to Patients With Advanced Solid Tumors

The main purpose of this study is to investigate the safety of LY3405105 in participants with
advanced cancer. The study has two parts (A and B). Participants will only enroll in one
part.


Inclusion Criteria:

- Have histological or cytological evidence of a diagnosis of a solid tumor cancer that
is advanced and/or metastatic

- Have available archived tissue for exploratory biomarker analysis

- Have adequate organ function

- Have discontinued all previous treatments for cancer and recovered from their side
effects

- Are able to swallow capsules/tablets

Exclusion Criteria:

- Have symptomatic central nervous system (CNS) malignancy or metastasis

- Have symptomatic human immunodeficiency virus (HIV), Hepatitis A, B, or C

- Have congestive heart failure

- Are breastfeeding
We found this trial at
4
sites
Toronto, Ontario
Principal Investigator: Phillippe Bedard
Phone: 4169464534
?
mi
from
Toronto,
Click here to add this to my saved trials
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Principal Investigator: Patricia M LoRusso
Phone: 203-785-3333
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Alison Schram
Phone: 646-888-5294
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
630 W 168th St
New York, New York
212-305-2862
Principal Investigator: Gary K Schwartz
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
?
mi
from
New York, NY
Click here to add this to my saved trials